SFI
AVEO

Susquehanna Fundamental Investments’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,130
Closed -$108K – 1603
2022
Q3 		$108K Buy
+13,130
New +$101K ﹤0.01% 1325
2022
Q1 		$264K Hold
47,186
– – 0.01% 1294
2021
Q4 		$221K Sell
47,186
-22,994
-33% -$143K 0.01% 1211
2021
Q3 		$434K Buy
70,180
+12,680
+22% +$75.8K 0.01% 1267
2021
Q2 		$379K Buy
+57,500
New +$396K 0.01% 1276

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Susquehanna Fundamental Investments's AVEO Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 13,130 shares — an estimated $108K sold.

Susquehanna Fundamental Investments first reported a position in AVEO in Q2 2021 and held it in 5 quarters. The position peaked at $434K in Q3 2021. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 13,130 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $108K.
  • Susquehanna Fundamental Investments first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2021 and held it in 5 quarters.
  • Susquehanna Fundamental Investments's AVEO Pharmaceuticals, Inc. position peaked at $434K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.